Oramed Pharmaceuticals Inc. · NASDAQ:ORMP

BML Investment Partners, L.P. reported a 6.55% stake in Oramed Pharmaceuticals Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 13, 2025

BML Investment Partners, L.P. reported a 6.55% stake in Oramed Pharmaceuticals Inc., 2,643,907 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).

Stake
6.55%
Shares
2,643,907
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BML Investment Partners, L.P.6.55%2,643,907

Source

View original at SEC

Related